SEC Form 4 · accession 0001078782-16-003003
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron John Reynolds
Officer — President and CEO · Director
Period of report
Jun 16, 2016
Accepted (ET)
Jun 20, 2016 · 1:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 16, 2016 | X | 4,000 | $3.00 | A | 32,897 | I | By Wife |
| Common StockF1 | Jun 16, 2016 | J | 3,540 | $3.39 | D | 29,357 | I | By Wife |
| Common Stock | Jun 16, 2016 | X | 12,500 | $2.50 | A | 41,857 | I | By Wife |
| Common StockF1 | Jun 16, 2016 | J | 9,219 | $3.39 | D | 32,638 | I | By Wife |
| Common Stock | Jun 16, 2016 | X | 12,500 | $3.00 | A | 45,138 | I | By Wife |
| Common StockF1 | Jun 16, 2016 | J | 11,062 | $3.39 | D | 34,076 | I | By Wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.00 | Jun 16, 2016 | X | 4,000 | D | Nov 25, 2012 | Nov 25, 2016 | Common Stock | 4,000 | 0 | I |
| Stock Option (Right to Buy) | $2.50 | Jun 16, 2016 | X | 12,500 | D | Feb 18, 2015 | Feb 18, 2019 | Common Stock | 12,500 | 0 | I |
| Stock Option (Right to Buy) | $3.00 | Jun 16, 2016 | X | 12,500 | D | Feb 18, 2016 | Feb 18, 2020 | Common Stock | 12,500 | 0 | I |
Explanation of responses
- F1Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such net exercise transaction.